Markets
← Back to Stocks
RMD
RESMED INC
Health Care · Health Care Equipment
$227.37
-0.50%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
ResMed beats Q2 EPS, 11% revenue growth drives pre-market rally
ResMed reported Q2 2026 EPS $2.81, beating forecasts by 2.93%, with revenue $1.4 billion and 11% growth achieving 19% increase in operating profits. Pre-market stock at $232.00, down 0.50% from close, while analysts see strong Buy consensus with $296.87 12-month target. The company's CPAP and respiratory care devices continue to see strong demand globally.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$33.2B
P/E (TTM)22.5
Forward P/E18.7
Beta0.89
Div Yield105.00%
Prev Close$228.51
RSI (14-Day)
14Oversold
0305070100
52-Week Range
$199.92$227.37$293.81
From High-22.6%
From Low+13.7%
Moving Averages
50d SMA
$253.04-10.1%
200d SMA
$259.25-12.3%
Price below 200d MA — bearish structure.
Returns
1W
-2.2%
1M
-12.2%
3M
-7.9%
6M
-15.9%
1Y
+4.2%
YTD
-6.9%
Volume
Today32K
20d Avg949K
Ratio0.03x